Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2018 Feb 1;77(2):183–192. doi: 10.1097/QAI.0000000000001578

Figure 4. Sensitivity analyses for (a) one-year implementation and (b) long-term implementation from a societal perspective.

Figure 4

Note: “Hite rate” represents number of newly diagnosed HIV infections per number enrolled; VBS = venue-based sampling; RDS-C = respondent driven sampling, confidential; RDS-A = respondent driven sampling, anonymous; QALY = quality adjusted life year